Ferrocene studies. IV. Some furan containing derivatives of ferrocene

Abstract

The condensation of ferrocenecarboxyhydrazide, ferrocenecarboxaldehyde and acetylferrocene with a number of furan derivatives is reported. The reaction of chalcones containing both the furan and the ferrocene nucleus with Phenylhydrazine and hydrazine proceeds to yield pyrazolines.

3,5-di-tert-butyl-1,4-benzoquinone ferrocenoylhydrazone and its zinc(II), palladium(II), and mercury(II) complexes: Structure and properties

“…It was of interest to extend a number of systems based on reverse hydrazones [16][17][18][19][20][21][22][23] using a spatially hindered fragment containing The IR spectrum of 3,5-di-tert-butyl-1,4-benzoquinone ferrocenenoylhydrazone III includes the bands of stretching vibrations of carbonyl groups of the hydrazone (1638 cm -1 ) and quinone fragments, the hydrazone C=N (1618 cm -1 ) and NH (3187 cm -1 ) bonds. The spectrum also contains the bands of torsional vibrations of cyclopentadiene rings at 481 and 500 cm -1 .…”

Ferrocenoylhydrazone of 2-N-tosylaminobenzaldehyde: Structure, properties, and complexing ability

“…Among compounds of this type, hydrazones containing ferrocenyl fragment are of special interest, some of which show second order non-linear optical properties [10][11][12] or biological activity [13][14][15]. Numerous complexes based on hydrazones of carbonyl ferrocene derivatives were described [16][17][18][19][20][21][22][23][24], whereas ferrocenoylhydrazones of carbonyl compounds are much less studied [25][26][27][28][29]. In particular, so far, only one ferrocenoylhydrazone was investigated by X-ray diffraction analysis (XRD) method [30].…”

Studies on Ferrocene and its Derivatives, VI. Cyclocondensation Reactions of Some Ferrocenyl Anils

“…Despite the wide interest in ferrocene chemistry relatively few ferrocene derivatives have been tested for biological activities [1][2][3][4][5]. The aromatic character, stability, low toxicity [6] and ease of substitution of ferrocene makes it ideal for use in drug design.…”